Package 30142-962-14

{"route": ["ORAL"], "spl_id": "7b7122bb-375b-4a86-a494-1dd8995083a9", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["495W7451VQ"], "rxcui": ["310621"], "spl_set_id": ["d434656a-221b-40fc-81ad-2b698be1aa33"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Kroger Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 CARTON (30142-962-14)  / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "30142-962-14", "marketing_start_date": "20220420"}], "brand_name": "Guaifenesin Extended Release", "product_id": "30142-962_7b7122bb-375b-4a86-a494-1dd8995083a9", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]"], "product_ndc": "30142-962", "generic_name": "Guaifenesin", "labeler_name": "Kroger Company", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Guaifenesin", "brand_name_suffix": "Extended Release", "active_ingredients": [{"name": "GUAIFENESIN", "strength": "1200 mg/1"}], "application_number": "ANDA209254", "marketing_category": "ANDA", "marketing_start_date": "20220420", "listing_expiration_date": "20261231"}